{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:52:30Z","timestamp":1771005150278,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Compr Ther"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1007\/s12019-000-0008-7","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T16:05:57Z","timestamp":1182960357000},"page":"190-196","source":"Crossref","is-referenced-by-count":4,"title":["Pulmonary hypertension update"],"prefix":"10.1007","volume":"26","author":[{"given":"Aidan","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Rounds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","unstructured":"Rich S, et al. World Symposium on Primary Pulmonary Hypertension. Evian, France, 1998. www.who.int\/ncd\/cvd\/pph.html"},{"issue":"1","key":"8_CR2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1378\/chest.104.1.236","volume":"104","author":"LJ Rubin","year":"1993","unstructured":"Rubin LJ. Primary pulmonary hypertension. Chest. 1993;104 (1):236\u2013250.","journal-title":"Chest"},{"issue":"4","key":"8_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/arrd.1983.127.4.437","volume":"127","author":"PJ McDonnell","year":"1983","unstructured":"McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis. 1983;127(4):437\u2013441.","journal-title":"Am Rev Respir Dis."},{"issue":"2","key":"8_CR4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","volume":"107","author":"S Rich","year":"1987","unstructured":"Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107(2):216\u2013223.","journal-title":"Ann Intern Med."},{"issue":"4","key":"8_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","volume":"70","author":"V Fuster","year":"1984","unstructured":"Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984;70(4):580\u2013587.","journal-title":"Circulation."},{"issue":"12","key":"8_CR6","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.1991.00400120073012","volume":"151","author":"SS Braman","year":"1991","unstructured":"Braman SS, Eby E, Kuhn C, Rounds S. Primary pulmonary hypertension in the elderly. Arch Intern Med. 1991;151(12):2433\u20132438.","journal-title":"Arch Intern Med."},{"issue":"1","key":"8_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.152.1.7599869","volume":"152","author":"JE Loyd","year":"1995","unstructured":"Loyd JE, Butler MG, Foroud TM, et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;152 (1):93\u201397.","journal-title":"Am J Respir Crit Care Med."},{"issue":"3","key":"8_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng0397-277","volume":"15","author":"WC Nichols","year":"1997","unstructured":"Nichols WC, Koller DL, Slovis B, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet. 1997;15(3):277\u2013280.","journal-title":"Nat Genet."},{"issue":"1","key":"8_CR9","first-page":"194","volume":"129","author":"JE Loyd","year":"1984","unstructured":"Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis. 1984;129(1):194\u2013197.","journal-title":"Am Rev Respir Dis."},{"issue":"2","key":"8_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327(2):70\u201375.","journal-title":"N Engl J Med"},{"issue":"4","key":"8_CR11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","volume":"333","author":"A Giaid","year":"1995","unstructured":"Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333(4):214\u2013221.","journal-title":"N Engl J Med."},{"issue":"24","key":"8_CR12","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","volume":"328","author":"A Giaid","year":"1993","unstructured":"Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328(24):1732\u20131739.","journal-title":"N Engl J Med."},{"issue":"5","key":"8_CR13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1172\/JCI1910","volume":"101","author":"SD Lee","year":"1998","unstructured":"Lee SD, Shroyer KR, Markham NE, et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998;101 (5):927\u2013934.","journal-title":"J Clin Invest."},{"key":"8_CR14","first-page":"A159","volume":"159","author":"E Klings","year":"1999","unstructured":"Klings E, Ieong MH, Simms RW, et al. The use of intravenous epoprostenol for the treatment of pulmonary hypertension associated with scleroderma. Am J Resp Crit Care Med. 1999;159:A159.","journal-title":"Am J Resp Crit Care Med."},{"issue":"10","key":"8_CR15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1096\/fasebj.9.10.7615157","volume":"9","author":"N Resnick","year":"1995","unstructured":"Resnick N, Gimbrone MA. Hemodynamic forces are complex regulators of endothelial gene expression. Faseb J. 1995;9(10):874\u2013882.","journal-title":"Faseb J."},{"issue":"4","key":"8_CR16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1378\/chest.112.4.980","volume":"112","author":"PC Kuo","year":"1997","unstructured":"Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive clinical features of portopulmonary hypertension. Chest. 1997;112 (4):980\u2013986.","journal-title":"Chest."},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.9783\/9781512801736-031","volume-title":"The Pulmonary Circulation: Normal and Abnormal","author":"HP Gurtner","year":"1990","unstructured":"Gurtner HP. Aminorex pulmonary hypertension. In: Fishman AP, ed. The Pulmonary Circulation: Normal and Abnormal. Philadelphia: University of Pennsylvania Press, 1990:397\u2013412."},{"issue":"9","key":"8_CR18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","volume":"335","author":"L Abenhaim","year":"1996","unstructured":"Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension: International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;335(9):609\u2013616.","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"8_CR19","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1136\/thx.52.2008.S63","volume":"52","author":"NF Voelkel","year":"1997","unstructured":"Voelkel NF. Appetite suppressants and pulmonary hypertension. Thorax. 1997;52(Suppl 3):S63\u201367.","journal-title":"Thorax."},{"issue":"3","key":"8_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herve","year":"1995","unstructured":"Herve P, Launay JM, Scrobohaci ML, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 1995;99(3):249\u2013254.","journal-title":"Am J Med."},{"issue":"9","key":"8_CR21","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.CIR.94.9.2216","volume":"94","author":"EK Weir","year":"1996","unstructured":"Weir EK, Reeve HL, Huang JMC, et al. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation. 1996;94(9):2216\u20132220.","journal-title":"Circulation."},{"issue":"6","key":"8_CR22","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1164\/ajrccm.158.6.9805002","volume":"158","author":"RM Tuder","year":"1998","unstructured":"Tuder RM, Radisavljevic Z, Shroyer KR, Polak JM, Voelkel NF. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension. Am J Respir Crit Care Med. 1998;158(6):1999\u20132001.","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"8_CR23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","volume":"100","author":"R Speich","year":"1991","unstructured":"Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest. 1991;100 (5):1268\u20131271.","journal-title":"Chest."},{"issue":"3","key":"8_CR24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm.155.3.9117037","volume":"155","author":"M Opravil","year":"1997","unstructured":"Opravil M, Pechere M, Speich R, et al. HIV-associated primary pulmonary hypertension: a case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med. 1997;155(3):990\u2013995.","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"8_CR25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(85)80477-0","volume":"6","author":"PJ Currie","year":"1985","unstructured":"Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6(4):750\u2013756.","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"8_CR26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/09031936.96.09040787","volume":"9","author":"R Kessler","year":"1996","unstructured":"Kessler R, Chaouat A, Weitzenblum E, et al. Pulmonary hypertension in the obstructive sleep apnea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J. 1996;9(4):787\u2013794.","journal-title":"Eur Respir J."},{"issue":"2","key":"8_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","volume":"327","author":"S Rich","year":"1992","unstructured":"Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327(2):76\u201381.","journal-title":"N Engl J Med."},{"issue":"6","key":"8_CR28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1997.00440270057005","volume":"157","author":"AS Malik","year":"1997","unstructured":"Malik AS, Warshafsky S, Lehrman S. Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension. Arch Intern Med. 1997;157(6):621\u2013625.","journal-title":"Arch Intern Med."},{"issue":"5","key":"8_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"GE D'Alonzo","year":"1991","unstructured":"D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115(5):343\u2013349.","journal-title":"Ann Intern Med."},{"issue":"5","key":"8_CR30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprotstenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334(5):296\u2013302.","journal-title":"N Engl J Med."},{"issue":"5","key":"8_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","volume":"338","author":"VV McLaughlin","year":"1998","unstructured":"McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998;338(5):273\u2013277.","journal-title":"N Engl J Med."},{"issue":"4","key":"8_CR32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/hrt.70.4.366","volume":"70","author":"TW Higenbottam","year":"1993","unstructured":"Higenbottam TW, Spiegelhalter D, Scott JP, et al. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J. 1993; 70(4):366\u2013370.","journal-title":"Br Heart J."},{"issue":"9","key":"8_CR33","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-124-9-199605010-00006","volume":"124","author":"H Olschewski","year":"1996","unstructured":"Olschewski H, Walmrath D, Schermuly R, et al. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med. 1996;124(9):820\u2013824.","journal-title":"Ann Intern Med."},{"issue":"6","key":"8_CR34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1378\/chest.109.6.1545","volume":"109","author":"RN Channick","year":"1996","unstructured":"Channick RN, Newhart JW, Johnson FW, et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest. 1996;109(6):1545\u20131549.","journal-title":"Chest."},{"issue":"2 Pt 1","key":"8_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/ajrccm.151.2.7842196","volume":"151","author":"O Sitbon","year":"1995","unstructured":"Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med. 1995;151(2 Pt 1):384\u2013389.","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"8_CR36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0735-1097(98)00361-1","volume":"32","author":"MJ Ricciardi","year":"1998","unstructured":"Ricciardi MJ, Knight BP, Martinez FJ, Rubenfire M. Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine. J Am Coll Cardiol. 1998;32(4):1068\u20131073.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"8_CR37","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0735-1097(92)90295-X","volume":"19","author":"BJ Schrader","year":"1992","unstructured":"Schrader BJ, Inbar S, Kaufmann L, Vestal RE, Rich S. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension. J Am Coll Cardiol. 1992;19(5):1060\u20131064.","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"8_CR38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","volume":"114","author":"S Rich","year":"1998","unstructured":"Rich S, Seidlitz M, Dodin E, et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest. 1998;114(3):787\u201392.","journal-title":"Chest."},{"issue":"6","key":"8_CR39","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/01.CIR.84.6.2275","volume":"84","author":"MK Pasque","year":"1991","unstructured":"Pasque MK, Trulock EP, Kaiser LR, Cooper JD. Single-lung transplantation for pulmonary hypertension: three-month hemodynamic follow-up. Circulation. 1991;84(6):2275\u20132279.","journal-title":"Circulation."},{"issue":"8","key":"8_CR40","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.CIR.92.8.2252","volume":"92","author":"MK Pasque","year":"1995","unstructured":"Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation. 1995;92(8):2252\u20132258.","journal-title":"Circulation."},{"issue":"2","key":"8_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(98)00238-1","volume":"32","author":"J Sandoval","year":"1998","unstructured":"Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32(2):297\u2013304.","journal-title":"J Am Coll Cardiol."}],"container-title":["Comprehensive Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12019-000-0008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12019-000-0008-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12019-000-0008-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T18:14:27Z","timestamp":1683915267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12019-000-0008-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s12019-000-0008-7","relation":{},"ISSN":["0098-8243","1559-1190"],"issn-type":[{"value":"0098-8243","type":"print"},{"value":"1559-1190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}